Peyronie’s Disease Treatment Market: Global Industry Insights, Growth Prospects, Business Overview, Growth Rate and Forecasts 2027 | Endo International plc

The global Peyronie’s Disease Treatment Market analysis provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. Peyronie’s Disease Treatment Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.

Click Here And Get PDF Brochure

What is Peyronie’s disease?

Peyronie’s disorder is a condition where scar tissue builds up around the head of the penis, making erections painful and highly unlikely. Peyronie’s disorder also appears to be more common in men who have a family history of such problems as diabetes, heart disease, and atherosclerosis (the buildup of cholesterol, fat, and other material around arteries). It has also been found to be more common in men who are obese or have low muscle mass. The scar tissue that forms can cover an area of about two square inches on the shaft or about twenty-five millimeters on an average shaft.

Global Peyronie’s disease treatment market is witnessing fastest growth in North America region

Growing number of studies and clinical trials associated with Peyronie’s disease is expected to expand size of the Peyronie’s disease treatment market. For example, in July 2019, The Journal of Sexual Medicine of the International Society for Sexual Medicine published a study ‘The Effectiveness of 3-D Computed Tomography in the Evaluation of Penile Deformities in Patients with Peyronie’s Disease: A Pilot Study, which concluded that computed tomography failed to provide more information than the evaluation with combined intracavernous injection stimulation test and current limitations and cost increases limit the use of 3D computed tomography in the assessment of Peyronie’s disease. Moreover, most of the healthcare associations are coming up with new guidelines about the treatment of Peyronie’s disease which is further projected to augment growth of the Peyronie’s disease treatment market. For example, in 2018, the Canadian Urological Association (CUA) presented new guidelines recommending the use of remodeling techniques based on Penile Traction Device of Andromedical (ANDROPEYRONIE) in combination with collagenase injections for the treatment of patients with Peyronie’s disease.

In April 2018, Paladin Labs Inc., a subsidiary of Endo International plc announced the launch of a new indication for XIAFLEX® (collagenase clostridium histolyticum), the first and only Health Canada-approved treatment for appropriate patients with Peyronie’s Disease

North America is expected to hold a dominant position in the global Peyronie’s disease treatment market over the forecast period owing to the increasing prevalence of a rare disease in the region. According to the National Institutes of Health, around 1 in 100 men in the United States over the age of 18 have been diagnosed with Peyronie’s disease. However, based on studies of men who reported having symptoms of Peyronie’s disease, researchers estimate that the actual number of men who have Peyronie’s disease is more than 1 in 10.

Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/61

Peyronie’s Disease Treatment Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Endo International plc

Main points in Peyronie’s Disease Treatment Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Peyronie’s Disease Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Peyronie’s Disease Treatment Industry Impact

Chapter 2 Global Peyronie’s Disease Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Peyronie’s Disease Treatment (Volume and Value) by Type
2.3 Global Peyronie’s Disease Treatment (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Peyronie’s Disease Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Peyronie’s Disease Treatment Market Analysis
Chapter 6 East Asia Peyronie’s Disease Treatment Market Analysis
Chapter 7 Europe Peyronie’s Disease Treatment Market Analysis
Chapter 8 South Asia Peyronie’s Disease Treatment Market Analysis
Chapter 9 Southeast Asia Peyronie’s Disease Treatment Market Analysis
Chapter 10 Middle East Peyronie’s Disease Treatment Market Analysis
Chapter 11 Africa Peyronie’s Disease Treatment Market Analysis
Chapter 12 Oceania Peyronie’s Disease Treatment Market Analysis
Chapter 13 South America Peyronie’s Disease Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Peyronie’s Disease Treatment Business
Chapter 15 Global Peyronie’s Disease Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com